How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

17,256 results for

Anxiety Non-pharmacologic Management

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Pharmacological interventions: Lack of clinically useful response predictors for treating aggression and agitation in Alzheimer's disease with citalopram

Pharmacological interventions: Lack of clinically useful response predictors for treating aggression and agitation in Alzheimer's disease with citalopram Lack of clinically useful response predictors for treating aggression and agitation in Alzheimer's disease with citalopram | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use (...) cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Lack of clinically useful response predictors for treating aggression and agitation in Alzheimer's disease

2016 Evidence-Based Mental Health

102. Pharmacological interventions: Clonidine: new use of an old medication to reduce stress-related substance use

Pharmacological interventions: Clonidine: new use of an old medication to reduce stress-related substance use Clonidine: new use of an old medication to reduce stress-related substance use | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Clonidine: new use of an old medication to reduce stress-related substance use Article Text Electronic pages Pharmacological interventions Clonidine: new use of an old medication to reduce stress

2016 Evidence-Based Mental Health

103. Pharmacological interventions: Antidepressant use with D-Cycloserine may block fear extinction

Pharmacological interventions: Antidepressant use with D-Cycloserine may block fear extinction Antidepressant use with d-Cycloserine may block fear extinction | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional (...) accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Antidepressant use with d-Cycloserine may block fear extinction Article Text Electronic pages Pharmacological interventions Antidepressant use with d -Cycloserine may block fear extinction Angela Fang , Sabine Wilhelm

2016 Evidence-Based Mental Health

104. Attention deficit hyperactivity disorder: diagnosis and management

with training and expertise in diagnosing and managing ADHD. See recommendation 1.4.3 for details of ADHD-focused information. 1.5.15 Offer medication to adults with ADHD if their ADHD symptoms are still causing a significant impairment in at least one domain after environmental modifications have been implemented and reviewed. See the recommendations on medication choice. [2018] [2018] 1.5.16 Consider non-pharmacological treatment for adults with ADHD who have: made an informed choice not to have (...) medication difficulty adhering to medication found medication to be ineffective or cannot tolerate it. [2018] [2018] Attention deficit hyperactivity disorder: diagnosis and management (NG87) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 19 of 621.5.17 Consider non-pharmacological treatment in combination with medication for adults with ADHD who have benefited from medication but whose symptoms are still causing

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

105. Pancreatic cancer in adults: diagnosis and management

care should be agreed and delivered. 1.4 Psychological support 1.4.1 Throughout the person's pancreatic cancer care pathway, specifically assess the psychological impact of: fatigue pain gastrointestinal symptoms (including changes to appetite) nutrition anxiety depression. 1.4.2 Provide people and their family members or carers (as appropriate) with information and support to help them manage the psychological impact of pancreatic cancer on their lives and daily activities. This should (...) Pancreatic cancer in adults: diagnosis and management P Pancreatic cancer in adults: diagnosis and ancreatic cancer in adults: diagnosis and management management NICE guideline Published: 7 February 2018 nice.org.uk/guidance/ng85 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived at after careful

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

106. Dementia: assessment, management and support for people living with dementia and their carers

1.3 Care coordination 19 1.4 Interventions to promote cognition, independence and wellbeing 20 1.5 Pharmacological interventions for dementia 21 1.6 Medicines that may cause cognitive impairment 25 1.7 Managing non-cognitive symptoms 25 1.8 Assessing and managing other long-term conditions in people living with dementia 27 1.9 Risks during hospital admission 29 1.10 Palliative care 30 1.11 Supporting carers 31 1.12 Moving to different care settings 32 1.13 Staff training and education 32 T erms (...) , or herbal formulations to treat dementia. 1.4.7 Do not offer cognitive training to treat mild to moderate Alzheimer's disease. 1.4.8 Do not offer interpersonal therapy to treat the cognitive symptoms of mild to moderate Alzheimer's disease. 1.4.9 Do not offer non-invasive brain stimulation (including transcranial magnetic stimulation) to treat mild to moderate Alzheimer's disease, except as part of a randomised controlled trial. 1.5 Pharmacological interventions for dementia Managing medicines for all

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

107. Renal replacement therapy and conservative management

. 1.1.4 Before starting dialysis in response to symptoms, be aware that some symptoms may be caused by non-renal conditions. T o find out why the committee made the recommendations on indications for starting renal replacement therapy and how they might affect practice, see rationale and impact. 1.2 Preparing for renal replacement therapy or conservative management When to assess When to assess 1.2.1 Start assessment for renal replacement therapy (RRT) or conservative management at least 1 year before (...) considered for a transplant if risk factors for poor outcomes have been identified; these may include: lack of social support neurocognitive issues non-adherence (medicines, diet, hospital appointments) poor understanding of process and complexities of treatment poorly controlled mental health conditions or severe mental illness substance misuse or dependence. T o find out why the committee made the recommendations on preparing for renal replacement therapy or conservative management – how to assess

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

108. Chronic obstructive pulmonary disease in over 16s: diagnosis and management

to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer. NICE has also produced: a guideline on antimicrobial prescribing for acute exacerbations of COPD a visual summary covering non-pharmacological management and use of inhaled therapies. Who is it for? Healthcare professionals Commissioners and providers People with COPD and their families and carers Chronic obstructive pulmonary disease in over 16s: diagnosis (...) . [2004] [2004] 1.2 Managing stable COPD NICE has also produced a visual summary covering non-pharmacological management and use of inhaled therapies. 1.2.1 For guidance on the management of multimorbidity, see the NICE guideline on multimorbidity. [2018] [2018] Chronic obstructive pulmonary disease in over 16s: diagnosis and management (NG115) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 14 of 65Smoking cessation

2018 National Institute for Health and Clinical Excellence - Clinical Guidelines

109. Treating interstitial cystitis: pharmacologic and non-pharmacologic options

Treating interstitial cystitis: pharmacologic and non-pharmacologic options The AFP Community Blog: Treating interstitial cystitis: pharmacologic and non-pharmacologic options | Monday, January 26, 2015 - Jennifer Middleton, MD, MPH An in the United States have interstitial cystitis (IC), a syndrome that can cause a variety of bothersome and uncomfortable urinary tract symptoms. The January 15 issue of AFP ; although researchers have yet to identify an effective long-term pharmacologic (...) physicians seeking to help their patients with IC may want to b ase their medication choice on each patient's symptoms. Although pentosan has been best studied for overall sy mptoms, cimetidine may be a useful alternative for patients whose predominant symptoms are nocturia and/or suprapubic pain. Although the for IC, the FPIN authors found conflicting evidence. While a smaller RCT (n = 50) showed benefit, a larger RCT (n = 271) did not. The AUA, however, lists all pharmacologic options for IC as second

2015 The AFP Community Blog

110. Efficacy of a transdiagnostic emotion-focused exposure treatment for chronic pain patients with comorbid anxiety and depression: a randomized controlled trial

Efficacy of a transdiagnostic emotion-focused exposure treatment for chronic pain patients with comorbid anxiety and depression: a randomized controlled trial The comorbidity between chronic pain and emotional problems has proven difficult to address with current treatment options. This study addresses the efficacy of a transdiagnostic emotion-focused exposure treatment ("hybrid") for chronic pain patients with comorbid emotional problems. Adults (n = 115) with chronic musculoskeletal pain (...) and functional and emotional problems were included in a 2-centre, parallel randomized controlled, open-label trial comparing this treatment to an active control condition receiving a guided Internet-delivered pain management treatment based on CBT principles (iCBT). The hybrid treatment (n = 58, 10-16 sessions) integrates exposure in vivo for chronic pain based on the fear-avoidance model with an emotion-regulation approach informed by procedures in Dialectical Behavior Therapy. The iCBT (n = 57; 8

2019 EvidenceUpdates

111. Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. (PubMed)

Exercise training undertaken by people within 12 months of lung resection for non-small cell lung cancer. Decreased exercise capacity and health-related quality of life (HRQoL) are common in people following lung resection for non-small cell lung cancer (NSCLC). Exercise training has been demonstrated to confer gains in exercise capacity and HRQoL for people with a range of chronic conditions, including chronic obstructive pulmonary disease and heart failure, as well as in people with prostate (...) -generating capacity of peripheral muscles, pressure-generating capacity of the respiratory muscles, dyspnoea and fatigue, feelings of anxiety and depression, lung function, and mortality.We searched for additional randomised controlled trials (RCTs) in the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library 2019, Issue 2 of 12), MEDLINE (via PubMed) (2013 to February 2019), Embase (via Ovid) (2013 to February 2019), SciELO (The Scientific Electronic Library Online) (2013

2019 Cochrane

112. Non-pharmacological interventions may comfort children having an anaesthetic

Non-pharmacological interventions may comfort children having an anaesthetic PEARLS Practical Evidence About Real Life Situations PEARLS are succinct summaries of Cochrane Systematic Reviews for primary care practitioners. They Non-pharmacological interventions may comfort children having an anaesthetic Clinical question How effective are non-pharmacological interventions in assisting induction of anaesthesia in children? Bottom line In single studies, a quiet environment, clown doctors, video (...) in children can be distressing for the child and also for their parents. Children can be given drugs to sedate them, but these drugs can have unwanted harmful effects, such as possible airway obstruction and behaviour changes after the operation. Some non-drug alternatives have been tested to see if they could be used instead of sedatives. Cochrane Systematic Review Yip P et al. Non-pharmacological interventions for assisting the induction of anaesthesia in children. Cochrane Reviews 2009, Issue 3

2011 Cochrane PEARLS

113. Talking therapy may relieve high levels of anxiety about health conditions

. What does current guidance say on this issue? The 2016 NICE guideline on multiple health conditions doesn’t specifically address health anxiety, although it does recommend being alert for anxiety or depression that may exist alongside medical conditions. The NICE guideline from 2011 on common mental health problems recommends cognitive behavioural therapy in the management of depression and anxiety disorders but does not cover health anxiety. What are the implications? This study highlights (...) cognitive behavioural therapy in the management of depression and anxiety disorders but does not cover health anxiety. What are the implications? This study highlights a common but largely hidden problem that is not currently addressed by healthcare services. It demonstrates that it is feasible to train health professionals to provide cognitive behavioural therapy for health anxiety in the outpatient setting and that it may help. However, the low participation rate is a problem. People with health

2018 NIHR Dissemination Centre

114. Depression and anxiety common in people with heart disease

, white males, so the findings may not apply to everyone. Patients considered a nurse-led intervention to personalise care was acceptable. The intervention included optimising medicines and facilitating referrals for psychological support. When asked, people with depression and coronary heart disease generally favoured non-medical treatments. These findings provide an insight into the scale of depression and anxiety amongst people with coronary heart disease. Overall costs of NHS care were increased (...) antidepressants or both. In their 2011 guidance on managing anxiety, NICE recommends that primary care professionals are aware of the potential signs of anxiety in people with chronic health problems. What are the implications? This multi-component study found that people with coronary heart disease were likely to experience depression and anxiety, reinforcing the need for primary care professionals to look out for these conditions in their patients. When discussing treatment, primary care professionals

2018 NIHR Dissemination Centre

115. An anxiety prevention programme is not effective over the long term in UK primary schools

compared to the usual school provision group. After two years, anxiety had reduced across the board and there was no difference between the three groups. Less than half (43.6%) of the starting number of children were tested after two years, although baseline differences between completers and non-completers were minimal. The FRIENDS programme was more faithfully implemented when health rather than school-led – not all of the core tasks and activities were delivered in the school led programmes (...) skills within all subject areas. These skills include problem-solving, coping, conflict management/resolution and understanding and managing feelings. This should be provided throughout primary education by appropriately trained teachers and practitioners. There is nothing in the current 2008 guidance advocating a specific programme to reduce anxiety and low mood such as the FRIENDS programme. What are the implications? The trial gives limited evidence to support the provision of FRIENDS - a specific

2018 NIHR Dissemination Centre

116. Treatment of mother-child interaction might be of value for childhood anxiety disorder

therapy (CBT) has been shown to work in adults and children. But previous research shows about 40% of children are still not free of their anxiety diagnosis after CBT. Children with anxiety disorders whose mothers also suffered from anxiety are particularly at risk of poorer treatment responses. One possible reason is that maternal anxiety, or parenting practices like overprotection, could reinforce or maintain the child disorder. This trial, called MaCH, was managed by the NIHR and jointly funded (...) a combination of strategies from existing family interventions for childhood anxiety and video-feedback techniques developed by the trial investigators. MaCH included 211 children and their mothers, both diagnosed with anxiety disorder. All children received individual CBT over eight weekly sessions. Mothers received eight weekly sessions of CBT or 10 sessions on mother-child interactions (two with the child, and eight on their own). Additional therapist sessions of non-directive counselling were provided

Full Text available with Trip Pro

2018 NIHR Dissemination Centre

117. Treatment of mother-child interaction might be of value for childhood anxiety disorder

therapy (CBT) has been shown to work in adults and children. But previous research shows about 40% of children are still not free of their anxiety diagnosis after CBT. Children with anxiety disorders whose mothers also suffered from anxiety are particularly at risk of poorer treatment responses. One possible reason is that maternal anxiety, or parenting practices like overprotection, could reinforce or maintain the child disorder. This trial, called MaCH, was managed by the NIHR and jointly funded (...) a combination of strategies from existing family interventions for childhood anxiety and video-feedback techniques developed by the trial investigators. MaCH included 211 children and their mothers, both diagnosed with anxiety disorder. All children received individual CBT over eight weekly sessions. Mothers received eight weekly sessions of CBT or 10 sessions on mother-child interactions (two with the child, and eight on their own). Additional therapist sessions of non-directive counselling were provided

Full Text available with Trip Pro

2018 NIHR Dissemination Centre

118. An anxiety prevention programme is not effective over the long term in UK primary schools

compared to the usual school provision group. After two years, anxiety had reduced across the board and there was no difference between the three groups. Less than half (43.6%) of the starting number of children were tested after two years, although baseline differences between completers and non-completers were minimal. The FRIENDS programme was more faithfully implemented when health rather than school-led – not all of the core tasks and activities were delivered in the school led programmes (...) skills within all subject areas. These skills include problem-solving, coping, conflict management/resolution and understanding and managing feelings. This should be provided throughout primary education by appropriately trained teachers and practitioners. There is nothing in the current 2008 guidance advocating a specific programme to reduce anxiety and low mood such as the FRIENDS programme. What are the implications? The trial gives limited evidence to support the provision of FRIENDS - a specific

2018 NIHR Dissemination Centre

119. Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents. (PubMed)

Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents. This is the first update of a review published in 2015, Issue 1. Chronic pain is common during childhood and adolescence and is associated with negative outcomes, such as increased severity of pain, reduced function, and low mood. Psychological therapies, traditionally delivered face-to-face with a therapist, are efficacious at reducing pain intensity and disability (...) , for the management of chronic pain in children and adolescents.We searched four databases (CENTRAL, MEDLINE, Embase, and PsycINFO) from inception to May 2018 for randomised controlled trials (RCTs) of remotely-delivered psychological interventions for children and adolescents with chronic pain. We searched for chronic pain conditions including, but not exclusive to, headache, recurrent abdominal pain, musculoskeletal pain, and neuropathic pain. We also searched online trial registries, reference sections

Full Text available with Trip Pro

2019 Cochrane

120. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. (PubMed)

Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Symptoms of anxiety and depression are common in inflammatory bowel disease (IBD). Antidepressants are taken by approximately 30% of people with IBD. However, there are no current guidelines on treating co-morbid anxiety and depression in people with IBD with antidepressants, nor are there clear data on the role of antidepressants in managing physical symptoms of IBD.The objectives were to assess (...) the efficacy and safety of antidepressants for treating anxiety and depression in IBD, and to assess the effects of antidepressants on quality of life (QoL) and managing disease activity in IBD.We searched MEDLINE; Embase, CINAHL, PsycINFO, CENTRAL, and the Cochrane IBD Group Specialized Register from inception to 23 August 2018. Reference lists, trials registers, conference proceedings and grey literature were also searched.Randomised controlled trials (RCTs) and observational studies comparing any type

2019 Cochrane

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>